Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × siremadlin × Clear all

NCT05599932 2025-07-09

Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms